Literature DB >> 9727055

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.

R Bals1, X Wang, Z Wu, T Freeman, V Bafna, M Zasloff, J M Wilson.   

Abstract

Previous studies have implicated the novel peptide antibiotic human beta-defensin 1 (hBD-1) in the pathogenesis of cystic fibrosis. We describe in this report the isolation and characterization of the second member of this defensin family, human beta-defensin 2 (hBD-2). A cDNA for hBD-2 was identified by homology to hBD-1. hBD-2 is expressed diffusely throughout epithelia of many organs, including the lung, where it is found in the surface epithelia and serous cells of the submucosal glands. A specific antibody made of recombinant peptide detected hBD-2 in airway surface fluid of human lung. The fully processed peptide has broad antibacterial activity against many organisms, which is salt sensitive and synergistic with lysozyme and lactoferrin. These data suggest the existence of a family of beta-defensin molecules on mucosal surfaces that in the aggregate contributes to normal host defense.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727055      PMCID: PMC508952          DOI: 10.1172/JCI2410

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis.

Authors:  D S Armstrong; K Grimwood; R Carzino; J B Carlin; A Olinsky; P D Phelan
Journal:  BMJ       Date:  1995-06-17

Review 2.  Defensins.

Authors:  T Ganz; R I Lehrer
Journal:  Curr Opin Immunol       Date:  1994-08       Impact factor: 7.486

3.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.

Authors:  E V Valore; C H Park; A J Quayle; K R Wiles; P B McCray; T Ganz
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

4.  Structure and diversity of the murine cryptdin gene family.

Authors:  K M Huttner; M E Selsted; A J Ouellette
Journal:  Genomics       Date:  1994-02       Impact factor: 5.736

5.  Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis.

Authors:  A B Thompson; T Bohling; F Payvandi; S I Rennard
Journal:  J Lab Clin Med       Date:  1990-02

6.  Elemental composition of human airway surface fluid in healthy and diseased airways.

Authors:  L Joris; I Dab; P M Quinton
Journal:  Am Rev Respir Dis       Date:  1993-12

7.  Increased bronchial chloride concentration in cystic fibrosis.

Authors:  H Gilljam; A Ellin; B Strandvik
Journal:  Scand J Clin Lab Invest       Date:  1989-04       Impact factor: 1.713

8.  Epithelial antibiotics induced at sites of inflammation.

Authors:  B S Schonwetter; E D Stolzenberg; M A Zasloff
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

9.  hBD-1: a novel beta-defensin from human plasma.

Authors:  K W Bensch; M Raida; H J Mägert; P Schulz-Knappe; W G Forssmann
Journal:  FEBS Lett       Date:  1995-07-17       Impact factor: 4.124

10.  Airway epithelial cells are the site of expression of a mammalian antimicrobial peptide gene.

Authors:  G Diamond; D E Jones; C L Bevins
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

View more
  167 in total

Review 1.  SNPing away at innate immunity.

Authors:  S J Chanock; C B Foster
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Differential expression of caprine beta-defensins in digestive and respiratory tissues.

Authors:  C Zhao; T Nguyen; L Liu; O Shamova; K Brogden; R I Lehrer
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 3.  A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein.

Authors:  O Levy
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 4.  Antimicrobial polypeptides in host defense of the respiratory tract.

Authors:  Tomas Ganz
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

5.  The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing.

Authors:  J Zabner; M P Seiler; J L Launspach; P H Karp; W R Kearney; D C Look; J J Smith; M J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 6.  Antimicrobial peptides: current status and therapeutic potential.

Authors:  Andreas R Koczulla; Robert Bals
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 7.  Endogenous production of antimicrobial peptides in innate immunity and human disease.

Authors:  Richard L Gallo; Victor Nizet
Journal:  Curr Allergy Asthma Rep       Date:  2003-09       Impact factor: 4.806

8.  Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster.

Authors:  E J Hollox; J A L Armour; J C K Barber
Journal:  Am J Hum Genet       Date:  2003-08-12       Impact factor: 11.025

9.  Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects.

Authors:  Raminder Aul; Jane Armstrong; Annelyse Duvoix; David Lomas; Brian Hayes; Bruce E Miller; Chris Jagger; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

Review 10.  The role of inflammation in the pathophysiology of CF lung disease.

Authors:  James F Chmiel; Melvin Berger; Michael W Konstan
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.